Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biomet Offers $280 Mil. For J&J’s DePuy Trauma Biz; Bid Facilitates Synthes Deal

This article was originally published in The Gray Sheet

Executive Summary

J&J expects the divestiture to reduce regulatory barriers to its pending $21 billion Synthes acquisition.

You may also be interested in...

Biomet Cites Q4 Sales Boost From JuggerKnot Sports Med Implants

The company’s sports, extremities and trauma products generated 14% growth last quarter with the help of its JuggerKnot Soft Anchor sports medicine products.

News In Brief

J&J completes $19.7 billion Synthes purchase. ReVision Optics’ PresbyLens presbyopia trial update. Mindray gains controlling stake in Dragonbio. More news briefs.

J&J’s Sedasys Sedation System Now “Approvable,” Though Some Questions Remain

Outstanding FDA questions pertain to follow-up data, user training and “post-market observance and those sorts of things,” CFO Dominic Caruso told investors during the firm’s first-quarter earnings call April 17.

Related Content


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts